Mike is the Director of Product Management for Schlafender Hase. He is committed to continuously improving the existing software portfolio and at the same time also delivering new and innovative solutions to exceed customer needs. He has more than 25 years of experience working with global packaging, labelling, pre-media and artwork management leaders in the pharmaceutical and medical device sectors.
Learn how new custom integration capabilities make it easy to connect TVT with the systems you already use; enabling greater automation, reducing manual effort, and accelerating review processes, all while maintaining the precision and compliance standards you rely on.
Top Regulatory Challenges in Food Labeling and How to Overcome Them
Food labeling plays a crucial role in protecting consumer health by providing information relating to food sources, nutrition and safety. Accurate and informative food labeling allows consumers to make informed dietary choices. Compliance with food labeling regulations is not only a legal requirement but also impacts brand reputation.
The Future of Labels: Embracing Digital Technology for Enhanced Efficiency
Think back to the early days of labeling – when medicines were sold by salespeople at events resembling circuses more than genuine health events. Consumers often had little to no knowledge of what was inside the medication bottle. In fact, the first US regulation on labeling, introduced in 1906, merely required that any listed contents were truthful.
RAPS Webinar Highlights: Learning the New Language of the EMA & The FDA – FHIR
As the healthcare industry undergoes rapid transformation, it is shifting away from product information (PI) based on physical and unstructured digital formats to electronic data formats offering greater accessibility, interoperability, and potential for global alignment. A key factor in this transformation is the data standard Fast Healthcare Interoperability Resources (FHIR).
Introducing TVT 12: A New Era in Compliance and Efficiency
With growing demands on regulatory professionals to ensure accuracy and efficiency, the newest version of the industry-trusted proofreading software, TVT 12 delivers enhancements that allow users to navigate complex document requirements with greater ease and confidence.
The Game-Changing Features of TVT 12: A New Era in Compliance and Efficiency
TVT 12 is here!
This annual update is packed exclusively with new features and improvements from customer requests that support key industry initiatives, boost efficiency, and add even more speed and detail to your document reviews.
The medical device sector’s surging regulatory burden: how are suppliers coping?
Regulators around the world are increasing their scrutiny of medical devices as these become more critical to patient outcomes. Referencing new research, Peter Muller and Mike Baird of Schlafender Hase consider how well Class 2 and 3 device manufacturers are adapting. Published in LifeSci Voice The global medical device industry is expected to be worth $886.80 billion by 2032[1]. It is no coincidence that company representatives now make up a growing proportion of attendees at Regulatory Affairs Professionals Society meetings. As devices become more critical to patient outcomes, regulators around the world are steadily increasing their associated safety controls. A new international benchmark report[2] considers how well manufacturers and their international partners are adapting to the rising regulatory demands. The 2024 study was conducted with 202 regulatory professionals at Class 2 and 3 device companies in the EU (Germany) and North America (the US). Emerging & intensifying regulatory requirements The research first tested medical device companies’ awareness of and current involvement with a number of increasingly prominent regulatory initiatives. E-labeling/eIFU E-labeling is high on the medical device regulation agenda on both sides of the Atlantic. Electronic information provision and management promotes standardization and consistency (e.g. of format and terminology), making it easier to manage and process the contents in any market. It also plays a key role in product traceability, a critical safety lever. Providing critical product information digitally (e.g. under expectations associated with electronic instructions for use, or eIFU) makes it easier to issue prompt updates, too. It also simplifies international content and translation management and, in the case of user advice or safety information, facilitates spontaneous online or mobile lookup by clinicians or patients. Crucially, e-labeling allows device manufacturers to provide more detail than can fit on a physical label. Currently, just under two-thirds (62%) of medical device companies are involved in e-labeling initiatives. EU companies are more likely to be actively involved in e-labeling than those in the US (71% vs 53%, respectively). This makes sense as the EU is ahead of the US with the practice; companies here are also less likely to outsource labeling as a service. FHIR/standardized data exchange Fast Healthcare Interoperability Resources is a proposed new global standard, designed to streamline data exchange and facilitate real-time information access for healthcare providers. It will shift the emphasis of content creation and management to ‘publishing’ rather than ‘printing’, promoting the digitization of the production and management of regulated medical device information and content. In the survey, three in five respondents (60%) were involved with the standard, rising to 67% for EU (German) respondents; in the US, only just over half were occupied with FHIR (FHIR is not as high profile in the US), though the FDA is encouraging manufacturers to adopt interoperability standards. UDI/device identification Unique device identification (UDI) employs a unique numeric or alphanumeric code to identify individual devices across the healthcare supply chain. Although approached slightly differently, a UDI system is advocated by both EMA and the FDA. Benefits include expedited and more targeted
Learning the New Language of the EMA & The FDA: FHIR
Watch our interactive discussion session focusing on the evolution and outlook of Fast Healthcare Interoperability Resources (FHIR).FHIR represents a significant step in how we manage and exchange information and is rapidly gaining acceptance. In this session, industry experts will provide an introduction to the FHIR initiative, explore some current applications as well as the impacts, benefits and prospective timelines.
How FMCG and CPG Companies Can Improve Regulatory Risk Management for Packaging
In the rapidly changing and highly competitive Fast-Moving Consumer Goods (FMCG) sector, labeling and packaging plays an important role in brand identity, over and above its purpose of protecting the physical product.
How FMCG and CPG Companies Can Improve Regulatory Risk Management for Packaging
In the rapidly changing and highly competitive Fast-Moving Consumer Goods (FMCG) sector, labeling and packaging plays an important role in brand identity, over and above its purpose of protecting the physical product.
RAPS Webinar: e-Labeling and what it means for Regulatory Teams
E-labeling is no longer a future concept. Regulatory agencies worldwide, including the EMA, FDA, and MHRA, are advancing digital product information initiatives. But what does this mean for your daily work as a regulatory professional? How will your submission and labeling processes change? And how can you prepare today to avoid last-minute compliance risks?
RAPS Webinar: e-Labeling and what it means for Regulatory Teams
E-labeling is no longer a future concept. Regulatory agencies worldwide, including the EMA, FDA, and MHRA, are advancing digital product information initiatives. But what does this mean for your daily work as a regulatory professional? How will your submission and labeling processes change? And how can you prepare today to avoid last-minute compliance risks?
Schlafender Hase Brings Pharma-Level content review and compliance to the CPG Industry with a new cloud-native version of TVT
TVT, Schlafender Hase’s flagship software, has long been the trusted standard for document and label review in the pharmaceutical industry. The new cloud-native version builds on the same proven comparison engine at the core of the desktop product. With a responsive web interface, scalable microservices architecture, and standards-based RESTful APIs, it delivers enhanced flexibility, intuitive usability, and seamless integration with existing document and artwork management systems, making world-class quality control more accessible to CPG teams.
Schlafender Hase Brings Pharma-Level content review and compliance to the CPG Industry with a new cloud-native version of TVT
TVT, Schlafender Hase’s flagship software, has long been the trusted standard for document and label review in the pharmaceutical industry. The new cloud-native version builds on the same proven comparison engine at the core of the desktop product. With a responsive web interface, scalable microservices architecture, and standards-based RESTful APIs, it delivers enhanced flexibility, intuitive usability, and seamless integration with existing document and artwork management systems, making world-class quality control more accessible to CPG teams.
